Keyphrases
Allopurinol
9%
Anti-leishmania
18%
Antibody Level
18%
Antigen Stimulation
27%
CanL
9%
Clinical Follow-up
9%
Clinical Improvement
18%
Clinical Recovery
9%
Clinical Staging
18%
Clinicopathological Findings
9%
Concanavalin A (Con A)
9%
Delayed Diagnosis
27%
Group Production
9%
IFN Production
100%
Immune Monitoring
9%
Leishmania
9%
Leishmania Infantum
100%
Leishmaniasis
100%
Meglumine Antimoniate
9%
Minimum Value
9%
Moderate to Severe
9%
Naturally Infected
9%
No Significant Difference
9%
Non-producer
63%
Parasitemia
54%
Producer Groups
9%
Prognostic Tool
9%
Quantitative ELISA
9%
Quantitative PCR
9%
Routine Diagnostic Tests
9%
Sandwich ELISA
9%
Sick Dogs
9%
Soluble Antigen
36%
Specific Antibodies
27%
Specific T Cells
9%
Supernatant
9%
T Cell Immunity
9%
Whole Blood
9%
Working Diagnosis
100%
Immunology and Microbiology
Adoptive Immunity
16%
Allopurinol
16%
Antigen
66%
Concanavalin A
16%
ELISA
16%
ELISA Sandwich
16%
Immunostimulation
50%
Laboratory Test
16%
Leishmania
50%
Leishmania infantum
100%
Leishmaniasis
100%
Meglumine Antimoniate
16%
Monospecific Antibody
66%
Parasitemia
100%
Real Time Polymerase Chain Reaction
16%
Supernatant
16%
T Cell
16%
Veterinary Science and Veterinary Medicine
Allopurinol
12%
Dog
100%
T Cell
12%